Clazakizumab is a monoclonal antibody designed to target and neutralize interleukin-6 (IL-6), a cytokine implicated in a wide array of inflammatory responses. This antibody exhibits high affinity and specificity for IL-6, making it a valuable tool in the study of cytokine-mediated processes. Clazakizumab has potential applications in the inhibition of the cytokine storm associated with SARS-CoV-2 infection in COVID-19 patients. Additionally, it is utilized in research focused on psoriatic arthritis (PsA) and renal antibody-mediated rejection, providing insights into the therapeutic mechanisms and potential clinical applications in these conditions.
Clazakizumab is a monoclonal antibody designed to target and neutralize interleukin-6 (IL-6), a cytokine implicated in a wide array of inflammatory responses. This antibody exhibits high affinity and specificity for IL-6, making it a valuable tool in the study of cytokine-mediated processes. Clazakizumab has potential applications in the inhibition of the cytokine storm associated with SARS-CoV-2 infection in COVID-19 patients. Additionally, it is utilized in research focused on psoriatic arthritis (PsA) and renal antibody-mediated rejection, providing insights into the therapeutic mechanisms and potential clinical applications in these conditions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
